Oscar Health News - November 2026
🟢 Oscar Health is trading 4.43% up in pre-market after raising full-year revenue outlook
Oscar Health is trading at $36.75, up 4.43% in pre-market after raising its full-year revenue outlook. - Q3 revenue was $5.1 billion, diluted EPS was $0.49,...
Oscar Health's third quarter 2026 revenue of $5.1B beat estimates while full year outlook was raised
Oscar Health reported a significant turnaround in the third quarter 2026, delivering profitability that far exceeded analyst expectations. The company achieved...
Oscar Health Inc Q3 2026 Earnings Preview: What Analysts Expect on November 05, 2026
Oscar Health is expected to report a Q3 2026 loss of $0.11 per share on consensus revenue of $4.72 billion, representing a substantial 58.1% year-over-year...